









Markets
/
Stocks
/
nasdaq-coo
/

Cooper Companies Inc

COO

74.520USD

+0.070+0.09%

Close 10/23, 16:00（ET）Quotes delayed by 15 min

14.81BMarket Cap

36.33P/E TTM



Cooper Companies Inc

74.520

+0.070+0.09%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

Overview

Company

Financials

Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score of Cooper Companies Inc

Currency: USD Updated: 2025-10-23

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. The company is performing well in the stock market, with strong fundamentals and technicals supporting the current trend. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Cooper Companies Inc's Score

Industry at a Glance

Industry Ranking

35 / 204

Overall Ranking

106 / 4685

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 21 analysts

Buy

Current Rating

83.797

Target Price

+11.73%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Cooper Companies Inc Highlights

StrengthsRisks

The Cooper Companies, Inc. is a global medical device company. The Company operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. It also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 17.74% year-on-year.

Overvalued

The company’s latest PE is 36.45, at a high 3-year percentile range.

Institutional Selling

The latest institutional holdings are 204.94M shares, decreasing 2.77% quarter-over-quarter.

Held by Larry Robbins

Star Investor Larry Robbins holds 280.69K shares of this stock.

Financial Health

Currency: USD Updated: 2025-10-23

The company's current financial score is 7.30, which is lower than the Healthcare Equipment & Supplies industry's average of 7.47. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 1.06B, representing a year-over-year increase of 5.73%, while its net profit experienced a year-over-year increase of 6.11%.

Score

Industry at a Glance

Previous score

7.30

Change



Financials

7.25

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

7.46

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

7.26

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

7.27

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

7.24

Key Metrics

Free cash flow

No Data

Cooper Companies Inc's Company Valuation

Currency: USD Updated: 2025-10-23

The company’s current valuation score is 6.98, which is lower than the Healthcare Equipment & Supplies industry's average of 7.16. Its current P/E ratio is 36.45, which is 11.55% below the recent high of 40.66 and 18.00% above the recent low of 29.89.

Score

Industry at a Glance

Previous score

6.98

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 35/204

No Data

Earnings Forecast

Currency: USD Updated: 2025-10-23

The company’s current earnings forecast score is 7.40, which is lower than the Healthcare Equipment & Supplies industry's average of 7.72. The average price target for Cooper Companies Inc is 85.00, with a high of 96.00 and a low of 64.00.

Score

Industry at a Glance

Previous score

7.40

Change

Support & Resistance

No Data

Analyst Rating

Based on 21 analysts

Buy

Current Rating

83.797

Target Price

+11.73%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

115

Total

Median

Average

Company name

Ratings

Analysts

Cooper Companies Inc

COO

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-10-23

The company’s current price momentum score is 8.57, which is higher than the Healthcare Equipment & Supplies industry's average of 7.16. Sideways: Currently, the stock price is trading between the resistance level at 78.30 and the support level at 68.67, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

8.56

Change

0.01

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(2)

Neutral(3)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

1.244

Buy

RSI(14)

62.906

Neutral

STOCH(KDJ)(9,3,3)

79.745

Neutral

ATR(14)

2.122

High Vlolatility

CCI(14)

98.911

Neutral

Williams %R

20.310

Buy

TRIX(12,20)

0.295

Sell

StochRSI(14)

70.928

Sell

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

74.186

Buy

MA10

72.013

Buy

MA20

70.535

Buy

MA50

69.788

Buy

MA100

70.742

Buy

MA200

77.939

Sell

Institutional Confidence

Currency: USD Updated: 2025-10-23

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.37. The latest institutional shareholding proportion is 103.09%, representing a quarter-over-quarter increase of 2.11%. The largest institutional shareholder is The Vanguard, holding a total of 24.16M shares, representing 12.15% of shares outstanding, with 2.08% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

24.16M

+1.77%

BlackRock Institutional Trust Company, N.A.

9.76M

-1.22%

State Street Investment Management (US)

8.66M

+1.23%

Capital World Investors

8.39M

+8.34%

Kayne Anderson Rudnick Investment Management, LLC

7.85M

-1.63%

T. Rowe Price Investment Management, Inc.

7.38M

+1.46%

T. Rowe Price Associates, Inc.

Star Investors

6.25M

+70.61%

Geode Capital Management, L.L.C.

5.21M

+2.52%

Neuberger Berman, LLC

5.06M

+40.32%

AllianceBernstein L.P.

3.78M

-2.52%

Risk Assessment

Currency: USD Updated: 2025-10-23

The company’s current risk assessment score is 7.16, which is higher than the Healthcare Equipment & Supplies industry's average of 4.64. The company's beta value is 1.01. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets.